Madhavi Pai

1.9k total citations
22 papers, 906 citations indexed

About

Madhavi Pai is a scholar working on Pharmacology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Madhavi Pai has authored 22 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Physiology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Madhavi Pai's work include Pain Mechanisms and Treatments (8 papers), Cannabis and Cannabinoid Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Madhavi Pai is often cited by papers focused on Pain Mechanisms and Treatments (8 papers), Cannabis and Cannabinoid Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Madhavi Pai collaborates with scholars based in United States, United Kingdom and Switzerland. Madhavi Pai's co-authors include Gin C. Hsieh, Prasant Chandran, Prisca Honoré, Michael D. Meyer, Michael J. Dart, Jennifer M. Frost, Tiffany Runyan Garrison, Anita K. Salyers, Erica J. Wensink and George Grayson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Madhavi Pai

22 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madhavi Pai United States 14 499 323 297 239 143 22 906
Prasant Chandran United States 15 380 0.8× 322 1.0× 425 1.4× 309 1.3× 99 0.7× 17 1.3k
Stephen J. Medhurst United Kingdom 13 208 0.4× 253 0.8× 605 2.0× 236 1.0× 29 0.2× 13 1.0k
María Gracia Sánchez‐Alonso Spain 16 259 0.5× 210 0.7× 84 0.3× 253 1.1× 51 0.4× 25 874
J. C. Brelière France 13 601 1.2× 1.1k 3.5× 293 1.0× 813 3.4× 72 0.5× 27 1.6k
Xavier Canat France 11 969 1.9× 919 2.8× 125 0.4× 486 2.0× 73 0.5× 12 1.6k
Jean-Claude Brelière France 13 423 0.8× 742 2.3× 216 0.7× 447 1.9× 46 0.3× 14 1.1k
Lucia Frau Italy 17 127 0.3× 482 1.5× 113 0.4× 285 1.2× 69 0.5× 34 1.1k
Maiko Gokoh Japan 13 752 1.5× 261 0.8× 132 0.4× 257 1.1× 79 0.6× 13 1.0k
Andy Billinton United Kingdom 13 222 0.4× 205 0.6× 139 0.5× 235 1.0× 15 0.1× 22 673
Katharine L. Chu United States 20 139 0.3× 319 1.0× 647 2.2× 349 1.5× 13 0.1× 28 1.2k

Countries citing papers authored by Madhavi Pai

Since Specialization
Citations

This map shows the geographic impact of Madhavi Pai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madhavi Pai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madhavi Pai more than expected).

Fields of papers citing papers by Madhavi Pai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madhavi Pai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madhavi Pai. The network helps show where Madhavi Pai may publish in the future.

Co-authorship network of co-authors of Madhavi Pai

This figure shows the co-authorship network connecting the top 25 collaborators of Madhavi Pai. A scholar is included among the top collaborators of Madhavi Pai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madhavi Pai. Madhavi Pai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manda, Sudhir, Bertrand Anz, Christopher B. Benton, et al.. (2024). A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia. Hematological Oncology. 42(3). e3274–e3274. 6 indexed citations
2.
Matthews, Tim, Marian S. Macsai, Ryan Merrell, et al.. (2023). A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin. Ophthalmic Research. 66(1). 1030–1043. 3 indexed citations
3.
Pai, Madhavi, et al.. (2023). A Retrospective Analysis of WhatsApp as a Mode of Teledermatology: A Need of the Present Bringing in a Newer Consultation Mode in Future. SHILAP Revista de lepidopterología. 7(1). 24–30. 2 indexed citations
4.
Cochrane, Tara, Alicia Enrico, David Gómez‐Almaguer, et al.. (2021). Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial. Leukemia & lymphoma. 63(2). 304–314. 6 indexed citations
5.
Manda, Sudhir, Bertrand Anz, Christopher B. Benton, et al.. (2021). Treatment Initiation of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in Patients with Untreated Acute Myeloid Leukemia. Blood. 138(Supplement 1). 1265–1265. 3 indexed citations
6.
Davids, Matthew S., Kirsten Fischer, Sandra Robrecht, et al.. (2021). ReVenG: A Phase 2 Study of Venetoclax Plus Obinutuzumab Retreatment in Patients with Relapsed Chronic Lymphocytic Leukemia. Blood. 138(Supplement 1). 2634–2634. 8 indexed citations
7.
Frost, Jennifer M., David A. DeGoey, Lei Shi, et al.. (2016). Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain. Journal of Medicinal Chemistry. 59(7). 3373–3391. 20 indexed citations
8.
Chu, Katharine L., Jun Xu, Madhavi Pai, et al.. (2013). Disturbances in slow-wave sleep are induced by models of bilateral inflammation, neuropathic, and postoperative pain, but not osteoarthritic pain in rats. Pain. 154(7). 1092–1102. 38 indexed citations
9.
Nelson, Derek W., Jennifer M. Frost, Karin Tietje, et al.. (2012). Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB2 receptor agonists for pain management. Bioorganic & Medicinal Chemistry Letters. 22(7). 2604–2608. 10 indexed citations
10.
Cowart, Marlon, Gin C. Hsieh, Lawrence A. Black, et al.. (2012). Pharmacological characterization of A-960656, a histamine H3 receptor antagonist with efficacy in animal models of osteoarthritis and neuropathic pain. European Journal of Pharmacology. 684(1-3). 87–94. 22 indexed citations
11.
Lee, Young-Lim, Madhavi Pai, Jill‐Desiree Brederson, et al.. (2011). Monosodium Iodoacetate-Induced Joint Pain is Associated with Increased Phosphorylation of Mitogen Activated Protein Kinases in the Rat Spinal Cord. Molecular Pain. 7. 39–39. 47 indexed citations
12.
Hsieh, Gin C., Madhavi Pai, Prasant Chandran, et al.. (2010). Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. British Journal of Pharmacology. 162(2). 428–440. 109 indexed citations
13.
Hsieh, Gin C., Prisca Honoré, Madhavi Pai, et al.. (2010). Antinociceptive effects of histamine H3 receptor antagonist in the preclinical models of pain in rats and the involvement of central noradrenergic systems. Brain Research. 1354. 74–84. 37 indexed citations
14.
Fan, Yaotian, et al.. (2009). Peripheral and central sites of action for the non‐selective cannabinoid agonist WIN 55,212‐2 in a rat model of post‐operative pain. British Journal of Pharmacology. 157(4). 645–655. 19 indexed citations
15.
Chin, Chih‐Liang, Madhavi Pai, Peter F. Bousquet, et al.. (2009). Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathways. Journal of Neuroimmunology. 211(1-2). 49–55. 24 indexed citations
16.
Hsieh, Gin C., Prasant Chandran, Anita K. Salyers, et al.. (2009). H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacology Biochemistry and Behavior. 95(1). 41–50. 69 indexed citations
17.
Chandran, Prasant, Madhavi Pai, Eric A.G. Blomme, et al.. (2009). Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis. European Journal of Pharmacology. 613(1-3). 39–45. 96 indexed citations
18.
Frost, Jennifer M., Michael J. Dart, Karin Tietje, et al.. (2008). Indol-3-yl-tetramethylcyclopropyl Ketones: Effects of Indole Ring Substitution on CB2 Cannabinoid Receptor Activity. Journal of Medicinal Chemistry. 51(6). 1904–1912. 69 indexed citations
19.
Yao, B. B., Gin C. Hsieh, Jennifer M. Frost, et al.. (2007). In vitroandin vivocharacterization of A‐796260: a selective cannabinoid CB2receptor agonist exhibiting analgesic activity in rodent pain models. British Journal of Pharmacology. 153(2). 390–401. 124 indexed citations
20.
Hradil, Vincent P., Terese Seifert, Peter R. Hollingsworth, et al.. (2007). Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI. British Journal of Pharmacology. 153(2). 367–379. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026